Abemaciclib is a cell cycle inhibitor that selectively targets cyclin-dependent kinases 4 and 6 (CDK4/6), with reported IC50 values of 2 nM and 10 nM in cell-free assays, respectively. It is a pharmaceutical raw material used in the manufacturing of kinase inhibitor-based products.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1231929-97-7
Abemaciclib mesylate
pharmaceutical raw material
Ganirelix
pharmaceutical raw material
Clofarabine
pharmaceutical raw material
5-trans-25-hydroxycholecalciferol
pharmaceutical raw material
PUBCHEM_44134997
pharmaceutical raw material
N-[5-[(4-ethylpiperazin-1-yl)methyl]-2-pyridinyl]-5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-amine
UZWDCWONPYILKI-UHFFFAOYSA-N
CCN1CCN(CC1)CC2=CN=C(C=C2)NC3=NC=C(C(=N3)C4=CC5=C(C(=C4)F)N=C(N5C(C)C)C)F